Thursday, March 23, 2023
News on Pathogens and Preparedness
Global Biodefense
  • Featured
  • COVID-19
  • Funding
  • Directory
  • Jobs
  • Events
  • Subscribe
No Result
View All Result
  • Featured
  • COVID-19
  • Funding
  • Directory
  • Jobs
  • Events
  • Subscribe
No Result
View All Result
Global Biodefense
No Result
View All Result
Home Funding News

NIH, CDC Announce Small Business Innovation Research Opportunity

by Global Biodefense Staff
August 2, 2012

The National Institutes of Health (NIH) and Centers for Disease Control and Prevention (CDC) are soliciting proposals from small businesses that possess capabilities to conduct innovative research that will contribute toward meeting the program objectives of the agencies. 

Highlighted topic areas include:
Integrated Multiplex Medical Diagnostics Platforms for Infectious Diseases
Assay Development for High-Throughput Screening of Chemicals of Toxicological Concern
Development of Nanoparticle Dengue Diagnostic Tests
Aerosolized Delivery of Anti-Tubercular Drugs
Improved Formulations for Approved First and Second line anti-Tuberculosis (TB) Drugs
Diagnostic Needs for Neglected Tropical Diseases (NTD) Programs
Rapid Screening Tests to Prevent Congenital Infections and Ensure Blood Safety
Development of User-Friendly Diagnostics of Arboviral Infections in Resource-Limited Settings
Visualizing Knowledge about Human Health and the Pathways of Translation
Automated Instrument to Clean Microtiter Plates
Technology to Generate Anti-Peptide Capture Reagents for Affinity-Enriched Proteomic Studies
Improving Safety and Efficacy of Red Blood Cells for Transfusion
Fluorescent Nanodiamonds for In Vitro and In Vivo Biological Imaging
Development of an Inactivated Rotavirus Vaccine for Use in Global Immunization
Thermostable Dry Measles Vaccine Formulation for Sublingual Administration

This activity, as part of the Small Business Innovation Research (SBIR) program, is designed to stimulate technological innovation in the private sector; strengthen the role of small business in meeting Federal research needs; and increase the commercial application of Federally-supported research results.

Additional topics are available under PHS-2013-1. The agencies will post a full solicitation on or about August 15, 2012 and begin accepting proposals at that time. The deadline for submission is November 13, 2012.

Tags: DengueMultiplexNeglected Tropical DiseasesNIHRequest for ProposalsThermostabilityVaccines

Related Posts

Partner Therapeutics’ Novel Approach to Stratify Sepsis Patients Gains Backing From BARDA
Funding News

Biopreparedness Research Virtual Environment (BRaVE) Initiative Backed by $105M DOE Funding

January 25, 2023
research team gathers in front of a window
CBRNE

UAMS Receives $3.4 Million to Study Radiation Injuries Caused by Nuclear Accidents and Bioterrorism

August 24, 2022
NIH to Further Invest in Point-of-Care Technologies Research Network
Biodetection

NIH to Further Invest in Point-of-Care Technologies Research Network

May 10, 2022
Supplemental Funding for Research at NIAID Regional Biocontainment Laboratories
Biosecurity

Supplemental Funding for Research at NIAID Regional Biocontainment Laboratories

May 5, 2022
Load More

Latest News

Biodefense Headlines – 12 March 2023

Biodefense Headlines – 12 March 2023

March 12, 2023
Partner Therapeutics’ Novel Approach to Stratify Sepsis Patients Gains Backing From BARDA

Biopreparedness Research Virtual Environment (BRaVE) Initiative Backed by $105M DOE Funding

January 25, 2023
Influenza Proteins Tilt and Wave in ‘Breath-like’ Motions

Influenza Proteins Tilt and Wave in ‘Breath-like’ Motions

January 25, 2023
Biodefense Headlines – 24 January 2023

Biodefense Headlines – 24 January 2023

January 24, 2023

Subscribe

  • About
  • Contact
  • Privacy
  • Subscribe

© 2022 Stemar Media Group LLC

No Result
View All Result
  • Featured
  • COVID-19
  • Funding
  • Directory
  • Jobs
  • Events
  • Subscribe

© 2022 Stemar Media Group LLC